Founded in 2007, Sequent Medical, Inc. is a privately-held venture backed medical device company dedicated to the development of innovative catheter-based neurovascular technologies. The company has invented and developed the proprietary Microbraid™ technology to create the WEB Aneurysm Embolization System, a compelling and versatile new option for the treatment of both ruptured and unruptured aneurysms. The WEB has received the CE mark and to date has been used to treat a wide variety of approximately 3,000 aneurysms worldwide. The WEB is not available for sale or use in the United States.

Sequent Medical, Inc. is headquartered in Aliso Viejo, California and has European operations based in Bonn, Germany.

CAUTION: The WEB Aneurysm Embolization System has received the CE mark. In the United States it is an investigational device limited by United States law to investigational use.